Ioannis Varthalitis

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence

Ioannis Varthalitis, Mabel Aoun, D. Daneau et al. · Cancer · 1993 · 81 citations · Full text

Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study

Evangelos Briasoulis, Gerasimos Aravantinos, George Kouvatseas et al. · BMC Cancer · 2013 · 76 citations · Full text

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

Dimitrios Pectasides, George Papaxoinis, Konstantine T. Kalogeras et al. · BMC Cancer · 2012 · 76 citations · Full text

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab

Anna G. Antonacopoulou, Anastasia G Eleftheraki, Foteinos‐Ioannis Dimitrakopoulos et al. · The Pharmacogenomics Journal · 2011 · 75 citations

Medicine, Colorectal Cancer, Pathology +7